All posts by admin

19Aug/13

Market Access Granted in France for Aggressive non-Hodgkin Lymphoma … – The Herald | HeraldOnline.com

August 19, 2013Monoclonal Anti-CD20 Antibodiesadmin

Market Access Granted in France for Aggressive non-Hodgkin Lymphoma …
The Herald | HeraldOnline.com
The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who …
CELL THERAPEUTICS INC : Market Access Granted in France for Aggressive …4-traders (press release)

all 7 news articles »

19Aug/13

GMC Hospital, Ajman holds blood donation drive – AME Info (press release)

August 19, 2013Organ Donoradmin

Gozo NewsGMC Hospital, Ajman holds blood donation driveAME Info (press release)The main objective of conducting the blood donation camp was to educate the community on the beneficial aspects of blood donation, promote awareness amongst the general publ…

19Aug/13

'Diabetes capital' tag a burden on India's heart – Hindustan Times

August 19, 2013Heartadmin

‘Diabetes capital’ tag a burden on India’s heart
Hindustan Times
Due to this, the economic burden due to diabetes in India is amongst the highest in the world. As per WHO estimates, mortality from diabetes, heart disease and stroke cost about $210 billion in India in 2005. Much of the heart disease and stroke in …

and more »

19Aug/13

Heart's own stem cells could help treat cardiac failure – India.Com Health

August 19, 2013Transplantationadmin

Heart’s own stem cells could help treat cardiac failure
India.Com Health
However, once heart failure develops the only curative treatment is heart transplantation. By revealing this robust homing mechanism, which causes cardiac stem cells to home to and repair the heart’s damaged muscle, the findings could lead to less …

and more »

18Aug/13

NC leader Pahadi passes away – Himalayan Times

August 18, 2013Transplantationadmin

NC leader Pahadi passes awayHimalayan TimesThe ailing Pahadi was admitted to hospital since second week of July after he returned home from India. He was taken to Delhi, India for the kidney transplantation but it could not be done, it is learnt. Pahad…

18Aug/13

Chronic heart failure trial enrolling patients at Moore Regional – Richmond County Daily Journal

August 18, 2013Organ Failureadmin

Chronic heart failure trial enrolling patients at Moore RegionalRichmond County Daily JournalA FirstHealth Moore Regional Hospital clinical trial is investigating whether the electrical treatment provided by a special type of pacemaker can keep a patie…

18Aug/13

To Your Good Health: Congestive heart failure affects body's fluids – Herald & Review

August 18, 2013Organ Failureadmin

To Your Good Health: Congestive heart failure affects body’s fluids
Herald & Review
Dear Dr. Roach: My husband was hospitalized with congestive heart failure. He returned home, grew weaker, and after three days was diagnosed with severe dehydration and passed away the following day. How can that happen so quickly? Can medication …

18Aug/13

'Efforts on to popularise organ donation' – The New Indian Express

August 18, 2013Organ Donoradmin

The New Indian Express

‘Efforts on to popularise organ donation‘
The New Indian Express
Though 22,000 people have registered as organ donors on drivers license cards, only 59 have come forward to donate their organs in the last five years. The government-appointed Zonal Coordination Committee of Karnataka (ZCCK) for Transplantation is …

18Aug/13

Heart failure drug approved by EU – Daventry Express

August 18, 2013Organ Failureadmin

Heart failure drug approved by EU
Daventry Express
A pill costing £1.40 a day “could save the lives of thousands of heart disease patients”, according to the Daily Mail. Several other newspapers have reported on the drug ivabradine, known by the brand name Procoralan, as European drug regulators have …

18Aug/13

5 Companies Leading the Fight Against Multiple Sclerosis – Motley Fool

August 18, 2013Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

5 Companies Leading the Fight Against Multiple Sclerosis
Motley Fool
Perhaps the most exciting of the bunch, in my opinion as least, is daclizumab, which is being co-developed with AbbVie and is being tested as a relapse-remitting MS therapy that’s injected just once every four weeks. Daclizumab itself is a humanized …

and more »

Archives